← Back to Search
Noninvasive Routes Of Proteins And Peptides Drug Delivery
Jitendra, P. Sharma, Sumedha Bansal, Arunabha Banik
Published 2011 · Medicine
Download PDFAnalyze on Scholarcy
Recent advances in the field of pharmaceutical biotechnology have led to the formulation of many protein and peptide-based drugs for therapeutic and clinical application. The route of administration has a significant impact on the therapeutic outcome of a drug. The needle and syringe is a well established choice of protein and peptide delivery which has some drawback related to patient and to formulation such as pain, cost, sterility etc. Thus, the noninvasive routes which were of minor importance as parts of drug delivery in the past have assumed added importance in protein and peptide drug delivery and these include nasal, ophthalmic, buccal, vaginal, transdermal and pulmonary routes. The pharmaceutical scientists have some approaches to develop the formulations for protein and peptide delivery by noninvasive routes. But, due to the physiochemical instability and enzymatic barrier of proteins and peptides there are several hurdle to develop suitable formulation. So there is need of penetration enhancers, enzyme inhibitors and suitable vehicles for noninvasive delivery to increase the bioavailability. In this review, the aim is to focus on the approaches to formulation of protein and peptide based drug administration by noninvasive route.
This paper references
Development of luteinizing hormone releasing hormone (LHRH) delivery systems for vaginal mucosal route
K. Han (1995)
Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
Y. Sudhakar (2006)
Absorption Enhancers for Nasal Drug Delivery
S. Davis (2003)
A comparison of thyrotropin-releasing hormone with analogs: influence of disposition upon pharmacology.
M. Hichens (1983)
Biomembrane permeability of peptides: strategies to improve their mucosal uptake.
A. Bernkop-Schnürch (2002)
STRUCTURE AND FUNCTION OF THE ORAL MUCOSA AND IMPLICATIONS FOR DRUG DELIVERY
C. Squier (1996)
Nasal systemic drug delivery
Y. Chien (1989)
Treatment of diabetes insipidus with synthetic vasopressin.
A. Spiegelman (1963)
Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
Yan Pan (2002)
Characterization of in Vitro Transdermal Iontophoretic Delivery of Insulin
A. Banga (1993)
Local Intravaginal Vaccination of the Female Genital Tract
L. Wassén (1996)
Enhanced Bioavailability of Subcutaneously Injected Insulin by Pretreatment with Ointment Containing Protease Inhibitors
M. Takeyama (2004)
BIOADHESIVE POLYMER SYSTEMS FOR PEPTIDE DELIVERY
H. Junginger (1990)
Dry powder formulations for pulmonary delivery
R. Malcolmson (1998)
Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.
E. Amaral (1999)
Challenges for the oral delivery of macromolecules
M. Goldberg (2003)
Formulation and Delivery of Proteins and Peptides. Design and Development Strategies.
J. Cleland (1995)
Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond.
S. Koevary (2003)
Nasal absorption of nafarelin acetate, the decapeptide [E-Nal
ST Anik (1985)
Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM).
S. Garg (2001)
Recent advances in protein and peptide drug delivery systems.
Dhirendra Kumar Malik (2007)
Transdermal drug delivery: overcoming the skin's barrier function.
Pfizer dumps Exubera
G. Mack (2007)
Drug delivery devices: issues in drug development.
P. Byron (2004)
Reduction of Blood Glucose Concentration With Insulin Eye Drops
G. Chiou (1988)
Thiomers: A New Generation of Mucoadhesive Polymers
M. Wagh (2009)
HYPOGLYCEMIA AFTER LIPOSOMIZED INSULIN IN THE RAT: 55
A. Moupti (1980)
Oral delivery of proteins: progress and prognostication.
R. Shah (2002)
Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity.
C. Mcmartin (1987)
Creation of transdermal pathways for macromolecule transport by skin electroporation and a low toxicity, pathway-enlarging molecule.
T. Zewert (1999)
Oral insulin delivery systems based on complexation polymer hydrogels
M. Morishita (2006)
Formulation and physiological factors influencing CNS delivery upon intranasal administration.
Tushar K Vyas (2006)
Peptide drug delivery: Colonic and rectal absorption
M. Mackay (1997)
Protein formulation and delivery
E. J. Mcnally (2008)
Influence of molecular weight and charge on nasal absorption of dextran and DEAE-dextran in rabbits
Maitani Yoshie (1989)
The lung as a route for systemic delivery of therapeutic proteins and peptides
R. Uchenna Agu (2001)
Systemic delivery of polypeptides with molecular weights of between 300 and 3500 through the eyes.
G. Chiou (1988)
Macromolecules as Novel Transdermal Transport Enhancers for Skin Electroporation
R. Vanbever (2004)
Effect of Formulation Additives upon the Intranasal Bioavailability of a Peptide Drug: Tetracosactide (ACTH1−24)
P. Wüthrich (2004)
Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles
A. Dyer (2004)
Effective vaginal absorption of insulin in diabetic rats and rabbits using polyacrylic acid aqueous gel bases
Morimoto Kazuhiro (1982)
Development and Evaluation of Controlled Release Nasal Drug Delivery Systems of Apomorphine
MI Ugwoke (1999)
Absorption from the vagina.
D. Benziger (1983)
Advantage of a new colloidal drug delivery system in insulin treatment of streptozotocininduced diabetic rats
Protein formulation and delivery. In: McNally EJ, editor
AR Clark (2000)
Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium.
Nazila Salamat-Miller (2005)
Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel
K. Morimoto (1985)
Pulmonary drug delivery: physiologic and mechanistic aspects.
J. Yu (1997)
The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
M. P. Desai (2004)
Hydrogel-Based lontotherapeutic Delivery Devices for Transdermal Delivery of Peptide/Protein Drugs
A. Banga (2004)
Intestinal transport and metabolism of glucose-conjugated kyotorphin and cyclic kyotorphin: metabolic degradation is crucial to intestinal absorption of peptide drugs.
T. Mizuma (2000)
Novel approaches for oral delivery of macromolecules.
A. Fasano (1998)
[Drug delivery to target the posterior segment of the eye].
F. Béhar-Cohen (2004)
Absorption of Polyethylene Glycols 600 Through 2000: The Molecular Weight Dependence of Gastrointestinal and Nasal Absorption
M. Donovan (2004)
Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment.
L. Langkjaer (1998)
Emerging strategies for the transdermal delivery of peptide and protein drugs
Yannic B. Schuetz (2005)
Development and in vivo evaluation of an oral insulin-PEG delivery system.
P. Calceti (2004)
Transmucosal macromolecular drug delivery.
C. Prego (2005)
Ocular drug bioavailability from topically applied liposomes.
V. H. Lee (1985)
Permeation enhancers in the transmucosal delivery of macromolecules.
S. Sharma (2006)
Effect of route of administration and distribution on drug action
L. Benet (2005)
Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea.
L. A. Johnson (2008)
Oral delivery of peptide drugs: barriers and developments.
J. Hamman (2005)
Vaginal bromocriptine in hyperprolactinemic patients and puerperal women
Valerio Maria Jasonni (1991)
Vaginal Bromocriptine: Pharmacology and Effect on Serum Prolactin in Normal Women
M. Vermesh (1988)
The epidemiology of diabetes mellitus and diabetic retinopathy.
J. C. Sánchez-Thorin (1998)
Indian Journal of Pharmaceutical Sciences 375 peptides and proteins
M Vermesh (2011)
Synergistic Effect of Enhancers for Transdermal Drug Delivery
S. Mitragotri (2004)
Penetration enhancement effect of Pz-peptide, a paracellularly transported peptide, in rabbit intestinal segments and Caco-2 cell monolayers
W. Yen (1995)
Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
A. Basu (2006)
Nasal absorption of nafarelin acetate, the decapeptide [D-Nal(2)6)]LHRH, in rhesus monkeys. I.
S. T. Anik (1984)
Dose-response curves after in vivo experimental chemotherapy: Influence of rouze of administration on biological outcomes
J. V. Moore (2004)
Pulmonary delivery of insulin
J. S. Patton (2006)
Development of controlled drug release systems based on thiolated polymers.
A. Bernkop-Schnürch (2000)
Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
M. E. Myles (2005)
Prodrug strategies to enhance the intestinal absorption of peptides
S. Gangwar (1997)
Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats.
C. Bosquillon (2004)
Oral Delivery of Peptide Drugs
J. Hamman (2012)
Synthesis of Palmitoyl Derivatives of Insulin and Their Biological Activities
M. Hashimoto (2004)
Buccal drug delivery: A challenge already won?
S. Rossi (2005)
The vagina as a route for systemic drug delivery.
Alamdar Hussain (2005)
Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides.
L. Illum (2001)
Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.
T. Aoyama (1984)
Transporters and receptors in ocular drug delivery: opportunities and challenges
S. Dey (2005)
VAGINAL DELIVERY OF CALCITONIN BY HYALURONIC ACID FORMULATIONS
J. Richardson (1999)
Enhancing paracellular permeability by modulating epithelial tight junctions.
Pulmonary Absorption of Insulin Mediated by Tetradecyl-β-Maltoside and Dimethyl-β-Cyclodextrin
Alamdar Hussain (2004)
The entrapment of biologically active substances in liposomes. I. Effect of oral administration of liposomally entrapped insulin in normal rats
V Dobre (1983)
Immunization of the Female Genital Tract with a DNA-Based Vaccine
J. Livingston (1998)
Tight junction modulation and its relationship to drug delivery.
N. Salama (2006)
Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives.
M. I. Ugwoke (2005)
Region-Dependent Role of the Mucous/Glycocalyx Layers in Insulin Permeation Across Rat Small Intestinal Membrane
Y. Aoki (2005)
Randomized trial of concurrent oxytocin with a sustained-release dinoprostone vaginal insert for labor induction at term.
F. C. Christensen (2002)
Rectal and vaginal absorption of peptides and proteins
S. Muranishi (1993)
Interleukin-2 liposomes for primary immune deficiency using the aerosol route.
R. Ten (2002)
The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals.
D. Pettit (1998)
Systemic delivery of enkephalin peptide through eyes.
G. Chiou (1988)
Buccal drug delivery
J. Smart (2005)
Ultrasonic atomization for spray drying: a versatile technique for the preparation of protein loaded biodegradable microspheres.
B. Bittner (1999)
Ocular delivery of progesterone using a bioadhesive polymer
Ho-Wah Hui (1985)
Synergistic Effect of Electric Field and Ultrasound on Transdermal Transport
J. Kost (2004)
Lack of age-associated immune dysfunction in mucosal-associated lymph nodes.
M. Szewczuk (1981)
Six hourly vaginal misoprostol versus intracervical dinoprostone for cervical ripening and labor induction
N. Agarwal (2003)
Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.
M. Morishita (2006)
Transdermal iontophoresis of insulin. II. Physicochemical considerations.
O. Pillai (2003)
This paper is referenced by
Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: A review
A. Sosnik (2014)
Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system.
L. Guilleminault (2014)
Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities.
Vibhuti Agrahari (2016)
Vibrational spectroscopic, DFT studies and molecular docking on (2R)-2-acetamido-N-benzyl-3-methoxy propanamide as an antineuropathic pain drug
A. Anuradha (2020)
Development of new artificial insemination extenders supplemented with GnRH analogues to induce ovulation and proteomic characterization of rabbit semen
Lucía Casares Crespo (2018)
Optimized preparation of lysozyme loaded dextran-chitosan nanoparticles using D-optimal design
Taraneh Hadi Esfahani (2019)
Molecular mechanism of transdermal co-delivery of interferon-alpha protein with gold nanoparticle – a molecular dynamics study
R. Gupta (2018)
Pharmaceutics, Drug Delivery and Pharmaceutical Technology Pulmonary Delivery of the Kv1.3-Blocking Peptide HsTX1(R14A) for the Treatment of Autoimmune Diseases
Liang Ying Jin (2016)
Using ion-pairs to modify salbutamol delivery to the lungs
Bridie Leigh Dutton (2018)
A design of experiments to optimize a new manufacturing process for high activity protein-containing submicron particles
Javier O Morales (2013)
Nanoparticle Insulin Drug Delivery — Applications and New Aspects
H. Elçioğlu (2014)
Protection of GnRH analogue by chitosan-dextran sulfate nanoparticles for intravaginal application in rabbit artificial insemination.
L. Casares-Crespo (2018)
NON INVASIVE DELIVERY OF PROTEIN AND PEPTIDE DRUGS: A REVIEW
P. Kotra Lakshmi (2017)
Oral administration of carvacrol/β-cyclodextrin complex protects against 6-hydroxydopamine-induced dopaminergic denervation
C. Ribeiro (2019)
Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
Ana Fortuna (2014)
Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally
Pablo Zubiaur (2019)
Ocular Delivery of Peptides and Proteins
R. Dahiya (2018)
Design of an In Situ Cross-Linked Eutectic Tablet for Enhanced Delivery of Gastro-Sensitive Proteins and Peptides.
Bibi F Choonara (2016)
A Noninvasive, Orally Stable, Mucosa-Penetrating Polyvalent Vaccine Platform Based on Hepatitis E Virus Nanoparticle
Shizuo George Kamita (2019)
In Silico Tools and Databases for Designing Peptide-Based Vaccine and Drugs.
S. Usmani (2018)
Quantitative analysis of recombinant glucocerebrosidase brain delivery via lipid nanoparticles
Meir Goldsmith (2018)
Microemulsion as drug delivery system for Peptides and Proteins
Landge Anil (2018)
Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization
Zachary Barry (2020)
Films loaded with insulin-coated nanoparticles (ICNP) as potential platforms for peptide buccal delivery.
Javier O Morales (2014)
Transdermal cellular membrane penetration of proteins with gold nanoparticles: a molecular dynamics study.
R. Gupta (2017)
Chitosan centered bionanocomposites for medical specialty and curative applications: A review.
M. Ahmad (2017)
Review of recently used techniques and materials to improve the efficiency of orally administered proteins/peptides
Y. H. Y. Ibrahim (2019)
The development of polycarbophil as a bioadhesive material in pharmacy
Zhaolu Zhu (2013)
Vulvodynia: A Review of the Literature
Bobbi Jo Loflin (2019)
Transdermal delivery of second-generation antipsychotics for management of schizophrenia; disease overview, conventional and nanobased drug delivery systems
Fatma S. El-Tokhy (2020)
Pulmonary Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] for the Treatment of Autoimmune Diseases.
Liang Jin (2016)
Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery
Rajiv Bajracharya (2019)See more